The pharmacological treatment of depression in adults with epilepsy (Q57544943)

Expert Opinion on Pharmacotherapy

Europe PubMed Central

title

The pharmacological treatment of depression in adults with epilepsy (English)

0 references

1 reference

Marco Mula

1

0 references

Ley Sander

object named as

Josemir W Sander

series ordinal

3

0 references

author name string

Bettina Schmitz

series ordinal

2

0 references

language of work or name

English

0 references

publication date

28 November 2008

0 references

published in

0 references

volume

9

0 references

issue

18

0 references

page(s)

3159-3168

0 references

cites work

Depression in epilepsy: a frequently neglected multifaceted disorder

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

The psychiatric comorbidity of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Patient-validated content of epilepsy-specific quality-of-life measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

The impact of epilepsy on subjective health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

The effect of seizure severity on quality of life in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Psychopathology in children and adolescents with epilepsy: an investigation of predictive variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Depression in epilepsy: etiology, phenomenology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Interactions between anticonvulsant and psychoactive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Phenytoin intoxication induced by fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Elevated serum phenytoin concentrations associated with coadministration of sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Lamotrigine toxicity secondary to sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Nefazodone may inhibit the metabolism of carbamazepine: three case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Effects of steady-state bupropion on the pharmacokinetics of lamotrigine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Antidepressants and seizures: clinical anecdotes overshadow neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Relevance of new psychotropic drugs for the neurologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Use of psychotropic drugs in patients with epilepsy: interactions and seizure risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Pharmacotherapy of Mood Disorders in Epilepsy: The Role of Newer Psychotropic Drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Citalopram as treatment of depression in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

The effects of lamotrigine on the pharmacokinetics of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Topiramate can cause lithium toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Influence of lithium carbonate on patients with temporal epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024

Bupropion and Anticonvulsant Drug Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802587024